Drug Type Small molecule drug |
Synonyms Pyp1 |
Target |
Action inhibitors |
Mechanism PDE10A inhibitors(Phosphodiesterase 10A inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC20H21N7O |
InChIKeyYLPZTDCVMOWRPZ-CVEARBPZSA-N |
CAS Registry1370527-16-4 |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Schizophrenia | Preclinical | United States | 09 Jan 2023 |





